What The Viewpoint Says: Questions regarding the safety of COVID-19 vaccination for patients with cancer are explored in this article.
Authors: Dimitrios P. Kontoyiannis, M.D., Sc.D.,Ph.D., of the University of Texas MD Anderson Cancer Center in Houston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2021.1218)
Editor's Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
###
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1218?guestAccessKey=deb70871-d54c-413f-a354-affb2bd968e5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051321
Journal
JAMA Oncology